Molecular imaging with contrast enhanced ultrasound.
Noninvasive cardiovascular imaging techniques are well-established for studying cardiovascular anatomy and physiology. Over the past decade contrast enhanced imaging techniques have been developed that are also able to characterize the molecular constituents of cardiovascular disease. In this regard, microbubble- and ultrasound-based techniques have the ability to assess a broad range of molecular components of cardiovascular pathology such as inflammation, recent ischemia, atherosclerosis, acute transplant rejection, angiogenesis, and thrombosis. The advantages of ultrasound- and microbubble-based approach include the ability to assess multiple molecular disease markers without exposure to ionizing radiation or prolonged imaging protocols. This review highlights the development of microbubble-based molecular imaging, describes successful experimental conditions in which they have been studied, and postulates the importance of translating this technique into the clinical practice.
Chadderdon
Scott M
SM
Cardiovascular Division, UHN 62, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
Kaul
Sanjiv
S
D000818:Animals; D015415:Biomarkers / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000000981:diagnostic imaging* / Q000378:metabolism*; D003287:Contrast Media / Q000493:pharmacokinetics*; D004452:Echocardiography / Q000379:methods*; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D015336:Molecular Probe Techniques; D009206:Myocardium / Q000378:metabolism*
D015415:Biomarkers; D003287:Contrast Media
Mol Imaging. 2007 Sep-Oct;6(5):289-96
18092513
J Am Soc Echocardiogr. 2002 May;15(5):396-403
12019422
Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):54-9
19834105
Circ Cardiovasc Imaging. 2008 Nov;1(3):244-56
19808549
Circulation. 2000 Nov 28;102(22):2745-50
11094042
Cardiovasc Res. 2009 Sep 1;83(4):636-42
19541670
Cardiovasc Res. 2009 Sep 1;83(4):653-62
19564152
Circulation. 2007 Jul 17;116(3):276-84
17592078
Circulation. 2001 Oct 23;104(17):2107-12
11673354
Circulation. 2009 Mar 17;119(10):1378-85
19255341
Circulation. 2007 Jan 23;115(3):345-52
17210843
J Nucl Med. 2008 Jun;49(6):871-8
18483100
Circulation. 2002 Apr 16;105(15):1764-7
11956115
Invest Radiol. 2002 Nov;37(11):587-93
12393970
Circulation. 2003 Jan 28;107(3):455-60
12551871
J Thorac Cardiovasc Surg. 1997 Jun;113(6):1100-8
9202691
Ann Thorac Surg. 2005 Jan;79(1):204-11
15620944
Am J Cardiol. 1998 Jun 18;81(12A):58G-61G
9662229
JACC Cardiovasc Imaging. 2009 Sep;2(9):1048-56
19761981
Thromb Res. 2009 May;124(1):70-4
19349068
Clin Cancer Res. 2007 Jan 1;13(1):323-30
17200371
Mol Imaging. 2009 Jul-Aug;8(4):209-20
19728975
FASEB J. 2003 Jun;17(9):984-92
12773481
Circulation. 2007 Apr 17;115(15):2076-86
17438163
Circ Res. 1999 Jul 23;85(2):199-207
10417402
Thromb Haemost. 2008 Aug;100(2):356-61
18690359
J Am Soc Echocardiogr. 1999 Dec;12(12):1015-21
10588775
Circulation. 2004 Mar 2;109(8):1056-61
14967733
Circulation. 2008 Jun 3;117(22):2902-11
18506006
J Am Coll Cardiol. 1990 Nov;16(5):1267-79
2229776
Circulation. 2005 Jun 21;111(24):3248-54
15956135
Circulation. 2003 Jul 15;108(2):218-24
12835214
Science. 1994 Apr 22;264(5158):569-71
7512751
Nat Med. 1998 Aug;4(8):934-8
9701246
J Am Coll Cardiol. 1995 Sep;26(3):793-9
7642875
J Clin Invest. 1993 Feb;91(2):379-87
7679406
Curr Probl Cardiol. 2007 Feb;32(2):51-96
17208647
J Thorac Cardiovasc Surg. 1992 Dec;104(6):1524-31
1453716
J Nucl Cardiol. 2004 Nov-Dec;11(6):733-43
15592197
Circ Res. 1994 Jun;74(6):1157-65
8187282
Circulation. 2000 Feb 15;101(6):668-75
10673260
Circulation. 1998 Nov 17;98(20):2187-94
9815874
Eur Heart J. 2007 Aug;28(16):2011-7
17526905
Stroke. 2007 May;38(5):1508-14
17379828
Nat Rev Cardiol. 2009 Jul;6(7):475-81
19506587
Circ Res. 1999 Jun 11;84(11):1237-44
10364560
Circulation. 2003 Jul 22;108(3):336-41
12835208
J Am Coll Cardiol. 1999 Mar;33(3):867-75
10080492